The Science of Selective Fat Oxidation
Tesamorelin is a stabilized synthetic analogue of Growth Hormone-Releasing Hormone (GHRH). Unlike direct HGH administration, which can flood the system and blunt natural rhythms, Tesamorelin acts as a secretagogue. It binds to the GHRH receptors in the pituitary gland, triggering a natural, pulsatile release of endogenous growth hormone.
In a laboratory environment, Tesamorelin is specifically valued for its tissue-specific action. Research indicates it primarily targets Visceral Adipose Tissue (VAT)—the deep, metabolically active fat surrounding internal organs—while having a minimal effect on subcutaneous fat.
Why Research Leads with Tesamorelin:
- Preservation of Feedback Loops: By stimulating the pituitary rather than replacing GH directly, the subject’s natural negative feedback system (somatostatin) remains intact.
- Metabolic Integrity: Studies show an average 18% reduction in visceral fat over a 26-week period in specific research models, alongside improvements in triglyceride levels.
- Cognitive Inquiry: Emerging research is exploring Tesamorelin’s potential impact on cognitive health and neuroprotection, due to the increase in circulating IGF-1 levels.
The Freedom Research Quality Standard
For high-fidelity research, purity is the only metric that matters. Our Tesamorelin is synthesized using Solid-Phase Peptide Synthesis (SPPS) and undergoes rigorous testing to ensure it meets the Freedom Standard:
- Purity: 99%+ HPLC Verified.
- Molecular Architecture: Stabilized with a trans-3-hexenoic acid group to resist enzymatic degradation.
- Format: Lyophilized (Freeze-Dried) white cake for maximum shelf-life and stability.
Storage Protocol: For long-term viability, keep lyophilized vials at -20°C. Once reconstituted with bacteriostatic water, store at 2-8°C and protect from light.